Highlights from the John Goldman Conference on CML 2017:
CML experts give their personal perspectives

Perspectives on biology and clinical aspects 
from Professor Jorge Cortes
MD Anderson Cancer Center
University of Texas, Houston (USA)

• Leukemic stem cells and microenvironment
• Biomarkers 
• Conceptual understanding of treatment-free remission 
• Treatment discontinuation with 2nd generation TKI's
• Update on the new ELN recommendations
• Patient-reported outcomes
• New modalities of monitoring patients
• Long-term outcomes from various clinical studies

 {rscomments off}